Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • oxaliplatin
Personalizing Oxaliplatin Dosing: Reducing Neurotoxicity in Stage III Colon Cancer—Insights from the LEANOX Trial
Posted inClinical Updates Wellness & Lifestyle

Personalizing Oxaliplatin Dosing: Reducing Neurotoxicity in Stage III Colon Cancer—Insights from the LEANOX Trial

Posted by By MedXY 08/07/2025
LBM-based oxaliplatin dosing significantly reduces peripheral neurotoxicity without compromising survival outcomes in adjuvant treatment for stage III colon cancer.
Read More
  • Understanding Inverted Nipples: Causes, Risks, and Solutions
  • Does Poor Emotional Health Increase the Risk of Breast Nodules?
  • Breast Nodules: How Close Are They to Breast Cancer?
  • Understanding Gynecological Inflammations: Symptoms, Prevention, and Care
  • Is Female Masturbation Harmful to Health? A Comprehensive Exploration
  • About us
  • Contact us
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease Antibiotics blood pressure breast cancer cancer cardiovascular health clinical trial clinical trials COPD Dementia diabetes diet dinh dưỡng epidemiology exercise FDA health healthcare Healthy Eating HIV Hypertension immunotherapy longevity MASLD men's health mental health multiple myeloma nutrition obesity Pregnancy prevention public health semaglutide sexual health sleep treatment Vaccine weight loss wellness women's health 临床试验 健康 女性の健康 女性健康

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top